Contribution of clinical, biological mini-puberty and genetic analysis in 57 46,XY DSD: a monocentric retrospective cohort
Hormone Research in Paediatrics · 2025
DOI: 10.1159/000542580 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hormone Research in Paediatrics, 2025. Verfasst von Chloé Marie und 7 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Endocrinology Department, CHU Bicêtre, Paris Saclay University, Reference Center for Rare Disease CRMR DevGen, Paris, France, chloe.marie@a…. Hauptthemen laut MEDLINE: Disorder of Sex Development, 46,XY, Genetic Testing, Puberty.
Abstract (Originalsprache)
Introduction
Differences of sex development (DSD) is a group of rare congenital conditions defined by chromosomal, gonadal and/or phenotypic discordance or atypical sex. The mini-puberty, corresponding to the transient postnatal activation of the hypothalamic-pituitary-gonadal axis, is an important diagnosis window in the clinical workup of infants with DSD. First objective to compare clinical data as well as hormone levels during minipuberty between patients with and without a genetic diagnose. Secondary objectives were to assess the positive predictive value of specific hormone levels at M2 , the mid-point of mini-puberty, of age to differentiate between patients with and without a genetic diagnose by NGS.
Methods
Our study included 57 children with 46,XY DSD born between September 2010 and August 2022 who had results from hormone level measurements during mini-puberty and a next-generation sequencing DSD gene panel.
Results
From genetic testing, the diagnostic yield was 49%. Hormone analysis during mini-puberty demonstrated variations in anti-Müllerian hormone, inhibin B, follicle-stimulating hormone and luteinizing hormone levels, with specific patterns observed in certain DSD conditions. Notably, levels of follicle-stimulating hormone >4 IU/L, anti-Müllerian hormone
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pediatric Endocrinology Department, CHU Bicêtre, Paris Saclay University, Reference Center for Rare Disease CRMR DevGen, Paris, France, chloe.marie@aphp.fr.
- Cytogenetics Department, CHU Bicêtre, Paris Saclay University, Paris, France.
- Genetics Department, CHU Bicêtre, Paris Saclay University, Paris, France.
- Biology Department, CHU Bicêtre, Assistance Publique-Hôpitaux de Paris Saclay University, Paris, France.
- Paediatric Endocrinology Department, CHU A.Trousseau, Paris Sorbonne University, Paris, France.
- Paediatric Endocrinology Department, CHU Necker, Paris-Cité University, Paris, France.
Zitieren
APA
Marie, C., Tosca, L., Bouligand, J., Ait-Tayeb, A. E., Trabado, S., Houang, M., Samara-Boustiani, D., & Bouvattier, C. (2025). Contribution of clinical, biological mini-puberty and genetic analysis in 57 46,XY DSD: a monocentric retrospective cohort. Hormone Research in Paediatrics. https://doi.org/10.1159/000542580
Vancouver
Marie C, Tosca L, Bouligand J, Ait-Tayeb AE, Trabado S, Houang M, et al. Contribution of clinical, biological mini-puberty and genetic analysis in 57 46,XY DSD: a monocentric retrospective cohort. Hormone Research in Paediatrics. 2025. doi:10.1159/000542580
BibTeX
@article{Marie2025,
author = {Marie, Chloé and Tosca, Lucie and Bouligand, Jérôme and Ait-Tayeb, Abd-El-Kader and Trabado, Severine and Houang, Muriel and Samara-Boustiani, Dinane and Bouvattier, Claire},
title = {Contribution of clinical, biological mini-puberty and genetic analysis in 57 46,XY DSD: a monocentric retrospective cohort},
journal = {Hormone Research in Paediatrics},
year = {2025},
doi = {10.1159/000542580}
}
EUVIMED